The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SAVE (Safe Accelerated Venetoclax Escalation): Initial results of a prospective, phase Ib study of venetoclax with an accelerated dose ramp-up in patients with CLL.
 
Jennifer Leigh Crombie
Consulting or Advisory Role - ADC Therapeutics; AstraZeneca (I); Genmab; Kite, a Gilead Company; MorphoSys/Incyte
Research Funding - Abbvie; Bayer; Genentech/Roche; Merck
 
Inhye E Ahn
No Relationships to Disclose
 
Svitlana Tyekucheva
No Relationships to Disclose
 
Reid Merryman
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Bristol Myers Squibb Foundation; Epizyme; Genmab; Intellia Therapeutics
Research Funding - Bristol-Myers Squibb; Genentech/Roche; Genmab; Merck
 
David Christopher Fisher
No Relationships to Disclose
 
Philippe Armand
Honoraria - Merck
Consulting or Advisory Role - ADC Therapeutics; astraZeneca; ATB Therapeutics; Bristol-Myers Squibb; Enterome; Foresight Diagnostics; Genentech/Roche; GenMab; Merck Sharp & Dohme; Regeneron; Tessa Therapeutics; Xencor
Research Funding - Adaptive Biotechnologies (Inst); Affimed Therapeutics (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); igm (Inst); Kite, a Gilead company (Inst); Merck Sharp & Dohme (Inst); Roche (Inst)
 
Josie Montegaard
Consulting or Advisory Role - Abbvie/Pharmacyclics; AstraZeneca
 
Marykate Kilcommons
No Relationships to Disclose
 
Celeste Carey
No Relationships to Disclose
 
Robert Black
No Relationships to Disclose
 
Jennifer R. Brown
Consulting or Advisory Role - Abbvie; Acerta/Astra-Zeneca; BeiGene; Bristol-Myers Squibb/Celgene/Juno; Catapult Therapeutics; Genentech/Roche; HUTCHMED; iOnctura; Janssen; Lilly; MEI Pharma; MorphoSys; Novartis; Pharmacyclics
Research Funding - BeiGene (Inst); Gilead Sciences (Inst); Loxo/Lilly (Inst); MEI Pharma (Inst); Secura Bio (Inst); Sun Pharma (Inst); TG Therapeutics (Inst)
 
Matthew Steven Davids
Honoraria - Aptitude Health; Axis Medical Education; Bio Ascend; Curio Science; Medscape; Peerview; Physicans' Education Resource; PlatformQ Health; Plexus; Research to Practice
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Ascentage Pharma; AstraZeneca; BeiGene; Bristol-Myers Squibb; Genentech; Genmab; Janssen; Lilly; Merck; MingSight; Ono Pharmaceutical; Secura Bio; Syros Pharmaceuticals; Takeda; TG Therapeutics
Research Funding - AbbVie (Inst); Ascentage Pharma (Inst); AstraZeneca (Inst); Genentech (Inst); Novartis (Inst); Secura Bio (Inst); TG Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Up-to-date royalties